Julie Beyrer

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Metastatic Breast Cancer

Machine Learning

Top Venues

Clinical epidemiology

Pharmacoepidemiology and drug safety

Future oncology (London, England)

Drugs - real world outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Rao, Yongmei Chen, Julie Beyrer, Emily Nash Smyth, Claudia Morato Guimaraes, Lacey M Litchfield, Lee Bowman, Garreth W Lawrence, Amit Aggarwal, Fabrice Andre
Clinical and Genomic Characteristics of Patients with HR+, HER2- Metastatic Breast Cancer Following Progression on a CDK4 and 6 Inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julie Beyrer, David R Nelson, Kristin M Sheffield, Yu-Jing Huang, Yiu-Keung Lau, Ana L Hincapie
Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data. Clinical epidemiology 15 (2023)
Julie Beyrer, David R Nelson, Kristin M Sheffield, Yu-Jing Huang, Yiu-Keung Lau, Ana L Hincapie
Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data. Clinical epidemiology 15 (2023)
Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno, Elizabeth Hadden, Hamed Abedtash, Angelo DeLuca, Garreth W Lawrence, Sarah Rybowski
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib. Drugs - real world outcomes 9 (4) (2022)
Julie Beyrer, Hamed Abedtash, Kenneth Hornbuckle, James F Murray
A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms. Journal of comparative effectiveness research 11 (7) (2022)
Julie Beyrer, Janna Manjelievskaia, Machaon Bonafede, Gregory Lenhart, Sandra Nolot, Diane Haldane, Joseph Johnston
Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data. Pharmacoepidemiology and drug safety 30 (5) (2021)
Katherine B Winfree, Cliff Molife, Patrick M Peterson, Yongmei Chen, Carla M Visseren-Grul, Mark S Leusch, Julie Beyrer, Anastasios Dimou
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations. Future oncology (London, England) 17 (22) (2021)
Julie Beyrer, David R Nelson, Kristin M Sheffield, Yu-Jing Huang, Tim Ellington, Ana L Hincapie
Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data. Pharmacoepidemiology and drug safety 29 (11) (2020)